To verify the correlation of ERBB2 and miR-193a-5p in ESCC patients, immunohistochemistry and in situ hybridization were performed to examine both ERBB2 and miR-193a-5p expression in clinical tissues (Figure 4A). The gene discussed is ERBB2; the disease is esophageal squamous cell carcinoma.